299. Cystic fibrosis Clinical trials / Disease details

Clinical trials : 1,695 / Drugs : 1,527 - (DrugBank : 268) / Drug target genes : 111 - Drug target pathways : 174

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04530383 (ClinicalTrials.gov)	February 14, 2022	24/8/2020	Effects of Metformin on Airway Ion Channel Dysfunction in Cystic Fibrosis-related Diabetes	A Randomized, Double-blind, Crossover Clinical Trial of Metformin in Those With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function	Cystic Fibrosis-related Diabetes;Cystic Fibrosis	Drug: Metformin Hydrochloride	University of Kansas Medical Center	NULL	Recruiting	18 Years	N/A	All	36	Phase 2	United States
2	EUCTR2009-009875-37-NL (EUCTR)	11/03/2009	21/01/2009	A placebo-controlled trial of insulin therapy with or without adjuvant metformin in patients with cystic fibrosis-related diabetes - Insulin therapy and adjuvant metformin in CFRD	A placebo-controlled trial of insulin therapy with or without adjuvant metformin in patients with cystic fibrosis-related diabetes - Insulin therapy and adjuvant metformin in CFRD	Cystic fibrosis-related diabetes MedDRA version: 9.1;Level: HLT;Classification code 10012602;Term: Diabetes mellitus (incl subtypes) MedDRA version: 9.1;Level: LLT;Classification code 10011762;Term: Cystic fibrosis	Trade Name: Metformine HCL 500 PCH	Staf Longziekten	NULL	Not Recruiting			Female: yes Male: yes	25		Netherlands